Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Scientific Reports|January 25, 2025
Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group studyNargiz Majidova, Hacı Arak, Faruk Recep Ozalp, et al.Breast Cancer Research and Treatment|August 9, 2024
Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG studyİsmail Beypınar, Hacer Demir, Şendağ Yaslıkaya, et al.Frontiers in Pharmacology|August 13, 2016
Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the FutureWinnie de Bruijn, Cristina Ibáñez, Pia Frisk, et al.Scientific Reports|October 9, 2024
The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) studyNeslihan Özyurt, Ali Alkan, Burcu Gülbağcı, et al.Scientific Reports|April 5, 2025
Efficacy of gemcitabine plus nab-paclitaxel in second-line treatment of metastatic pancreatic cancerYasin Sezgin, Oğur Karhan, Mehmet Naci Aldemir, et al.Expert Review of Clinical Pharmacology|December 10, 2014
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Brian Godman, Rickard E Malmström, Eduardo Diogene, et al.Frontiers in Pharmacology|February 7, 2018
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian CountriesTomasz Bochenek, Vafa Abilova, Ali Alkan, et al.Journal of Chemotherapy (Florence, Italy)|March 18, 2024
Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) studyHasan Cagri Yildirim, Caner Kapar, Baris Koksal, et al.Cancer Investigation|May 20, 2021
Efficacy and Safety of Trastuzumab Emtansine in Her2 Positive Metastatic Breast Cancer: Real-World ExperienceAykut Bahçeci, Semra Paydaş, Naziye Ak, et al.Head & Neck|April 21, 2023
Major and minor salivary gland cancers: A multicenter retrospective studyMuhammet Bekir Hacioglu, Bulent Erdogan, Murat Bardakcı, et al.Pageof 10